Opioid Prescribing: Safe Practice, Changing Lives – Webinar
December 14 @ 12:00 pm - 3:00 pm
Thee Health Resources and Services Administration, Office of Regional Operations (Region III), In collaboration with the American Society for Addiction Medicine (ASAM) and the Central East Addiction Technology Transfer Center.
DESCRIPTION: We now know that overdoses from prescription opioids are a driving factor in the 15-year increase in opioid overdose deaths. Since 1999, the amount of prescription opioids sold in the U.S. has nearly quadrupled, yet there has not been an overall change in the amount of pain that Americans report. This comprehensive course, developed by experts from Collaborative for REMS Education (CO*RE), incorporates all six units outlined in the FDA blueprint for safe opioid prescribing. Attend this webinar if you want to be able to:
· Counsel patients and caregivers about safer use of opioids;
· Describe strategies for diagnosing and managing opioid-addicted patients; and
· Practice techniques for safe opioid prescribing.
PARTICIPANTS: This webinar is designed for healthcare and human service providers including physicians, physician assistants, nurse practitioners, nurse midwives, nurses, counselors, social workers, case managers, and other staff who interact with patients, who work in multiple types of settings including primary care, geriatric care, maternal and child health care, Head Start programs, STD/HIV & reproductive health care, mental health, addictions, health departments, hospitals, health centers, schools, and community health settings. Prescribers of extended-release and long-acting opioids are particularly welcome, including pain specialists, primary care physicians, physician assistants, nurse practitioners, advanced practice nurses, dentists, addiction medicine physicians, psychiatrists and other physicians and clinicians who prescribe opioids.
FACULTY: Edwin Salsitz, MD, DFASAM
Dr. Edwin Salsitz has been an attending physician in the Beth Israel Medical Center, Division of Chemical Dependency, New York City, since 1983, and is an Assistant Professor of Medicine at the Mount Sinai School of Medicine. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. Dr. Salsitz is certified by both the American Board of Addiction Medicine (ABAM) and the Board of Internal Medicine and Pulmonary Disease. He has published and lectures frequently on addiction medicine topics.
· Continuing Medical Education (CME) is available for Physicians, Physician Assistants, and Nurses (CME is accepted by ACCNE as continuing education for nursing), offered by the American Society for Addiction Medicine.
· Applications have been submitted by the CE ATTC for continuing education credits for:
o Social Workers (in partnership with the Beckley Treatment Center, application submitted to the National Association of Social Workers)
o Health Educators (application submitted to The National Commission for Health Education Credentialing
o Addiction Professionals (application submitted to The Association for Addiction Professionals)
ASAM’s CO*RE REMS CME Information
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Addiction Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This course has been designated as an approved CME Activity by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 3 AMA PRA Category 1 Credit(s)™ to the CME requirement for Part II: Lifelong Learning and Self-Assessment.
RPC Commercial Support Disclosure Statement
This educational activity is supported by an independent educational grant from the extended-release and long-acting (ER/LA) Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com or a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration (FDA).
Presented by the American Society of Addiction Medicine, a member of the Collaborative on REMS Education (CO*RE), 10 interdisciplinary organizations working together to improve pain management and prevent adverse outcomes.
CME is provided based on the following learning objectives:
· Describe appropriate patient assessment for treatment with extended-release and long-acting (ER/LA) opioid analgesics, evaluating risks and potential benefits of ER/LA therapy, as well as possible misuse.
· Apply proper methods to initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics, applying best practices including accurate dosing and conversion techniques, as well as appropriate discontinuation strategies.
· Demonstrate accurate knowledge about how to manage ongoing therapy with ER/LA opioid analgesics and properly use evidence-based tools while assessing for adverse effects.
· Employ methods to counsel patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal.
· Review/assess general and product-specific drug information concerning ER/LA opioid analgesics and identifying potential adverse effects of ER/LA opioids.